Literature DB >> 9468350

Brain imaging of schizophrenia--the dopamine hypothesis.

L Farde1.   

Abstract

The dopamine hypothesis of schizophrenia was formulated 30 years ago and postulates that the symptoms of schizophrenia are related to an increased central dopaminergic neurotransmission. The two fundamental assumptions that underlay the dopamine hypothesis of schizophrenia have received support from brain imaging studies on the dopamine system. There is a high occupancy of central D2-dopamine receptors in patients that are treated with clinically effective doses of classical antipsychotic drugs and recent studies indicate an abnormal function of the presynaptic dopaminergic neuron. Early reports of elevated postsynaptic D2-dopamine receptors in schizophrenic brains post mortem have, however, not been consistently confirmed by brain imaging studies of young neuroleptic-naïve patients with schizophrenia. Suitable methods are now being developed for brain imaging of the dopamine system in the limbic and neocortical regions that are of central interest in schizophrenia research.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9468350     DOI: 10.1016/s0920-9964(97)00121-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

Review 1.  The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Authors:  Jenny Lam; Nichole Coleman; April Lourdes A Garing; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

Review 2.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

Review 3.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Authors:  Andrée Lessard; Martin Savard; Fernand Gobeil; Joseph P Pierce; Virginia M Pickel
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

5.  Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.

Authors:  Carissa M Coulston; Michael Perdices; Antony F Henderson; Gin S Malhi
Journal:  Schizophr Res Treatment       Date:  2010-07-27

Review 6.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

Review 7.  Auditory verbal hallucinations as atypical inner speech monitoring, and the potential of neurostimulation as a treatment option.

Authors:  Peter Moseley; Charles Fernyhough; Amanda Ellison
Journal:  Neurosci Biobehav Rev       Date:  2013-10-12       Impact factor: 8.989

Review 8.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.